TradeProfina Unveils Revolutionary Algorithm for Instant Market Reversal Alerts GlobeNewswire August 25, 2025 Austin, Texas, Aug. 25, 2025 (GLOBE NEWSWIRE) — TradeProfina, a recognized leader in real-time market analytics, has officially rolled out its newest trading algorithm designed to capture market reversals as they occur. The system provides traders with instant buy and sell alerts […]
Sionna Therapeutics Announces First Subjects Dosed in Phase 1 Trial Evaluating NBD1 Stabilizer, SION-451, in Proprietary Dual Combinations in Development for the Treatment of Cystic Fibrosis Dosing initiated for SION-451 combined with SION-2222 and SION-451 combined with SION-109 in healthy volunteers; topline data anticipated in mid-2026 GlobeNewswire August 25, 2025 WALTHAM, Mass., Aug. 25, 2025
MEXC Launches Airdrop+ Event with 75,000 USDT Prize Pool to Celebrate Listing of Camp Network (CAMP) GlobeNewswire August 25, 2025 VICTORIA, Seychelles, Aug. 25, 2025 (GLOBE NEWSWIRE) — MEXC, a leading global cryptocurrency exchange, today announced it will list Camp Network (CAMP) at 09:00 UTC on August 27, 2025. To celebrate the listing, MEXC is
New Evidence Published Supporting Use of DecisionDx(R)-SCC Test in Guiding and Improving Treatment Pathway Decisions in NCCN High-Risk Cutaneous Squamous Cell Carcinoma GlobeNewswire August 25, 2025 New validation study shows DecisionDx-SCC significantly outperforms current staging systems in predicting risk of local recurrence and metastasis for NCCN high-risk patients Clinician survey confirms test results align with
iBio Announces Closing of $50 Million Public Offering GlobeNewswire August 25, 2025 Total gross proceeds of $100 million if all Series G warrants and Series H warrants are exercised for cash Financing was led by Balyasny Asset Management and included participation from Cormorant Asset Management, Adage Capital Partners LP, Ally Bridge Group, Marshall Wace, Coastlands
Beam Therapeutics to Participate in Upcoming September 2025 Investor Conferences GlobeNewswire August 25, 2025 CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that management will participate in fireside chats at the following upcoming investor conferences: Citi's 2025 Biopharma
Climb Bio to Present at Upcoming September 2025 Investor Conferences GlobeNewswire August 25, 2025 WELLESLEY HILLS, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that members of its executive team will participate in the upcoming investor conferences detailed below. Cantor
Major Drilling to Release Results for its First Quarter on September 8, 2025 Management to Host Webcast/Conference Call on Tuesday, September 9, 2025 at 8:00am EDT GlobeNewswire August 25, 2025 MONCTON, New Brunswick, Aug. 25, 2025 (GLOBE NEWSWIRE) — Major Drilling Group International Inc. (TSX: MDI) (the “Company”) will release its first quarter results, ended
EDAP to Participate in the H.C. Wainwright 27th Annual Global Investment Conference GlobeNewswire August 25, 2025 AUSTIN, Texas, August 25, 2025 — EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to participate in a fireside chat and host 1×1
Biogen and Stoke Therapeutics Announce Presentations of Clinical Data from Studies of Zorevunersen for the Potential Treatment of Dravet Syndrome at the 36th International Epilepsy Congress GlobeNewswire August 25, 2025 – 3-year data from open-label extension (OLE) studies demonstrate the potential for disease modification with durable seizure reductions and improvements in cognition and behavior on